Evaluation of the efficacy, safety, and side effects of secukinumab in patients with moderate-to-severe psoriasis: real-world data from a retrospective multicenter study
Abstract Background: Clinical studies have demonstrated that IL-17A inhibition with secukinumab is effective for clearing the skin of patients with psoriasis and has a favorable safety profile. Objective: The authors aim to determine whether secukinumab is effective and safe for the treatment of m...
Gardado en:
| Principais autores: | , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Sociedade Brasileira de Dermatologia
2022-09-01
|
| Series: | Anais Brasileiros de Dermatologia |
| Assuntos: | |
| Acceso en liña: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962022000500566&tlng=en |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|